Barclays’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.5M Sell
913,578
-905,083
-50% -$59.5M 0.01% 676
2026
Q1
$129M Buy
1,818,661
+222,302
+14% +$17.5M 0.03% 419
2025
Q4
$131M Sell
1,596,359
-156,955
-9% -$12.2M 0.03% 396
2025
Q3
$132M Buy
1,753,314
+164,821
+10% +$12.3M 0.03% 404
2025
Q2
$118M Buy
1,588,493
+239,394
+18% +$16.7M 0.03% 418
2025
Q1
$109M Sell
1,349,099
-128,293
-9% -$11M 0.03% 395
2024
Q4
$116M Sell
1,477,392
-1,289,731
-47% -$110M 0.03% 363
2024
Q3
$260M Buy
2,767,123
+837,983
+43% +$70.3M 0.07% 206
2024
Q2
$150M Buy
1,929,140
+321,828
+20% +$26.3M 0.05% 290
2024
Q1
$146M Sell
1,607,312
-13,764
-0.8% -$1.15M 0.05% 295
2023
Q4
$125M Buy
1,621,076
+414,318
+34% +$29M 0.05% 342
2023
Q3
$82.1M Buy
1,206,758
+68,647
+6% +$4.99M 0.05% 359
2023
Q2
$92.5M Buy
1,138,111
+641,399
+129% +$51.2M 0.06% 299
2023
Q1
$40.7M Buy
+496,712
New +$35.5M 0.02% 550

Other funds holding GEHC

Barclays's GEHC Position: Q2 2026 in Review

Barclays reduced its GE HealthCare (GEHC) stake by 50% in Q2 2026, selling an estimated $59.5M and leaving 913,578 shares worth $58.5M. The position accounts for 0.01% of the portfolio, ranked #676.

Barclays first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $260M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Barclays held 913,578 shares of GE HealthCare worth $58.5M as of Q2 2026.
  • Barclays sold 905,083 GE HealthCare shares in Q2 2026, an estimated $59.5M.
  • GE HealthCare made up 0.01% of Barclays's portfolio in Q2 2026, its #676 holding.
  • Barclays first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Barclays's GE HealthCare position peaked at $260M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.